Analysts convey bullish views on the company's prospects, wi...
Analysts convey bullish views on the company's prospects, with reduced estimated losses and upgraded revenue estimates. However, issues like dilutive stock issuance hint at potential risks.
New Forecasts: Here's What Analysts Think The Future Holds For Beam Therapeutics Inc. (NASDAQ:BEAM)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment